Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹64Cr
Rev Gr TTM
Revenue Growth TTM
-43.13%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

ELIXIR
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | -106.4 | 234.3 | -22.1 | 7,275.0 | 2,735.0 | 210.8 | 205.3 | 2.4 | -125.0 | -25.9 | -40.3 | 120.4 |
| 2 | 2 | 2 | 2 | 2 | 3 | 3 | 4 | 6 | 7 | 7 | 6 |
Operating Profit Operating ProfitCr |
| 351.7 | 67.1 | 72.5 | 72.7 | 84.8 | 79.4 | 83.8 | 38.7 | 241.2 | 38.9 | 40.3 | 55.4 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| -2 | 3 | 5 | 4 | 14 | 11 | 15 | 2 | -10 | 5 | 4 | 7 |
| 0 | 0 | 1 | 1 | 3 | 3 | 4 | 1 | -2 | 1 | 2 | 2 |
|
Growth YoY PAT Growth YoY% | -139.0 | 161.8 | -27.3 | 322.4 | 501.1 | 180.7 | 177.0 | -62.6 | -179.4 | -57.2 | -79.6 | 357.1 |
| 441.7 | 64.6 | 67.1 | 53.9 | 67.2 | 58.3 | 60.9 | 19.7 | 213.1 | 33.7 | 20.8 | 40.9 |
| -3.4 | 3.9 | 5.4 | 4.1 | 13.6 | 10.9 | 14.4 | 1.5 | -10.8 | 4.7 | 2.9 | 6.9 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| 206.2 | -61.8 | 189.0 | -18.4 | -65.1 | -117.7 | 3,051.8 | 27.4 | -83.8 | 765.4 | 8.7 | -11.3 |
| 2 | 2 | 3 | 4 | 3 | 4 | 5 | 6 | 6 | 7 | 15 | 25 |
Operating Profit Operating ProfitCr |
| 83.6 | 46.6 | 78.3 | 62.4 | 3.7 | 704.4 | 74.5 | 76.2 | -51.5 | 77.7 | 56.7 | 20.9 |
Other Income Other IncomeCr | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 1 | 2 |
Interest Expense Interest ExpenseCr | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 1 | 2 | 2 | 2 |
Depreciation DepreciationCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
| 9 | 3 | 9 | 6 | 0 | -5 | 14 | 17 | -3 | 26 | 18 | 5 |
| 3 | 1 | 2 | 2 | 0 | 0 | 1 | 4 | 1 | 5 | 5 | 2 |
|
| 492.3 | -63.4 | 185.3 | -38.9 | -106.3 | -1,842.2 | 337.0 | 6.2 | -126.4 | 711.7 | -39.7 | -76.3 |
| 59.8 | 57.1 | 56.4 | 42.2 | -7.6 | 837.5 | 67.3 | 56.0 | -91.1 | 64.4 | 35.7 | 9.5 |
| 8.4 | 2.9 | 8.8 | 5.4 | -0.4 | -6.6 | 15.7 | 16.5 | -4.2 | 26.9 | 16.1 | 3.8 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 |
| 13 | 14 | 18 | 21 | 20 | 15 | 23 | 31 | 28 | 43 | 51 | 54 |
Current Liabilities Current LiabilitiesCr | 2 | 2 | 3 | 3 | 2 | 9 | 32 | 30 | 19 | 28 | 35 | |
Non Current Liabilities Non Current LiabilitiesCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 19 | 21 | 27 | 30 | 29 | 26 | 61 | 69 | 43 | 71 | 84 | |
Non Current Assets Non Current AssetsCr | 9 | 9 | 9 | 10 | 9 | 13 | 11 | 14 | 25 | 25 | 32 | |
Total Assets Total AssetsCr |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 1 | 1 | -3 | 2 | 2 | 13 | -2 | 5 | 6 | -17 | 2 |
Investing Cash Flow Investing Cash FlowCr | 0 | -2 | 3 | -2 | 0 | -9 | -3 | 0 | 2 | 2 | -5 |
Financing Cash Flow Financing Cash FlowCr | -1 | 1 | 0 | 0 | -2 | -1 | 14 | -2 | -12 | 14 | 5 |
|
Free Cash Flow Free Cash FlowCr | 1 | 1 | -3 | 1 | 2 | 13 | -2 | 4 | 6 | -17 | 1 |
| 16.4 | 52.7 | -42.3 | 48.0 | -873.4 | -248.1 | -16.5 | 35.3 | -174.0 | -81.2 | 15.8 |
CFO To EBITDA CFO To EBITDA% | 11.7 | 64.6 | -30.4 | 32.5 | 1,794.2 | -295.0 | -14.9 | 26.0 | -307.6 | -67.3 | 10.0 |
| Financial Year | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 37 | 21 | 20 | 26 | 21 | 21 | 17 | 22 | 20 | 51 | 78 |
Price To Earnings Price To Earnings | 7.8 | 14.3 | 3.0 | 8.5 | 0.0 | 0.0 | 1.8 | 2.3 | 0.0 | 3.3 | 8.4 |
Price To Sales Price To Sales | 3.1 | 4.8 | 1.6 | 2.6 | 5.6 | -53.3 | 0.8 | 0.9 | 4.6 | 1.5 | 2.2 |
Price To Book Price To Book | 1.9 | 1.1 | 0.8 | 1.0 | 0.8 | 1.0 | 0.6 | 0.6 | 0.6 | 1.1 | 1.4 |
| 3.7 | 9.7 | 2.1 | 4.3 | 153.2 | -4.2 | 1.5 | 1.4 | -8.3 | 2.6 | 4.9 |
Profitability Ratios Profitability Ratios |
| 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 | 100.0 |
| 83.6 | 46.6 | 78.3 | 62.4 | 3.7 | 704.4 | 74.5 | 76.2 | -51.5 | 77.7 | 56.7 |
| 59.8 | 57.1 | 56.4 | 42.2 | -7.6 | 837.5 | 67.3 | 56.0 | -91.1 | 64.4 | 35.7 |
| 47.6 | 15.1 | 37.1 | 21.1 | -0.2 | -20.6 | 31.7 | 34.0 | -3.7 | 38.3 | 22.8 |
| 34.4 | 12.3 | 29.4 | 15.6 | -1.0 | -25.1 | 42.7 | 34.9 | -10.1 | 43.3 | 22.3 |
| 23.3 | 8.0 | 19.0 | 10.5 | -0.7 | -13.4 | 16.8 | 15.7 | -5.1 | 21.7 | 10.9 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
Elixir Capital Limited is a Mumbai-based investment holding company and a veteran player in the Indian financial services landscape. With over **30 years** of market experience, the Group has evolved from a traditional proprietary trading and broking house into a diversified financial services provider. The company is currently undergoing a strategic pivot, leveraging digital technology and financial literacy to capture the under-penetrated retail wealth management market in India.
---
### Group Structure and Strategic Ownership
Elixir Capital operates primarily as a holding entity, exercising control over a suite of specialized financial subsidiaries. As of **March 31, 2025**, the company maintains a **74% ownership stake** in its primary operating arms:
| Entity Name | Relationship | Core Activities |
| :--- | :--- | :--- |
| **Elixir Equities Private Limited (EEPL)** | Subsidiary | SEBI Registered Stock Broker, Portfolio Manager, Research Analyst, and CDSL Depository Participant. |
| **Elixir Wealth Management Private Limited** | Step-down Subsidiary | Wealth management and financial advisory services. |
| **Dipan Mehta Commodities Private Limited** | Step-down Subsidiary | Commodity broking and related financial services. |
The Group is backed by a strong promoter commitment, with the Promoter and Promoter Group holding a significant **71.29%** stake (**41,37,000 shares**), ensuring alignment between management and minority shareholders.
---
### The "PaisaSmart" Ecosystem: Digital Transformation Strategy
A cornerstone of Elixir’s forward-looking strategy is its **Fintech Division**, branded as **PaisaSmart**. This initiative aims to transition the Group from a proprietary trading-heavy model to a scalable, fee-based "Financial Services Group."
* **Investor Education & Content:** The **PaisaSmart YouTube channel** serves as a top-of-funnel lead generation tool, boasting **116,000 subscribers** (up from **50,000** in earlier cycles). It focuses on high-quality financial literacy to build brand trust.
* **AI-Driven Distribution:** In **February 2025**, the company launched a **WhatsApp-based AI chatbot** to simplify mutual fund investing. This tool facilitates seamless account opening and direct transactions.
* **Proprietary Advisory Tools:** Unlike generic distributors, Elixir offers **Proprietary MF Ratings** and **Customized Baskets** (goal-based, risk-adjusted portfolios) developed by seasoned professionals, offered to users at **zero cost**.
* **Hybrid Service Model:** To differentiate from "pure-play" robo-advisors, Elixir employs a hybrid approach, combining automated technology with **Dedicated Relationship Managers** for personalized human guidance.
* **Regional Market Penetration:** To capture diverse Indian demographics, services are currently offered in **five languages**: **English, Hindi, Marathi, Gujarati, and Tamil**.
---
### Financial Performance and Market Sensitivity
The Group’s revenue model is bifurcated between stable service fees and volatile investment income. Performance is highly sensitive to stock market cycles, specifically trading volumes and price movements.
| Metric (Consolidated) | FY 2024-25 | FY 2023-24 | FY 2022-23 |
| :--- | :--- | :--- | :--- |
| **Total Revenue** | **₹36.20 Crore** | **₹34.66 Crore** | **₹4.50 Crore** |
| **Net Profit / (Loss)** | **₹12.64 Crore** | **₹20.96 Crore** | **(₹3.43 Crore)** |
| **Dividend per Share** | **₹1.25** | **₹1.25** | **₹1.25** |
| **Paid-up Share Capital**| **₹5.80 Crore** | **₹5.80 Crore** | **₹5.80 Crore** |
**Key Financial Insights:**
* **Revenue Volatility:** The jump from **₹4.50 Crore** in FY23 to over **₹36 Crore** in FY25 highlights the impact of bullish market conditions on the valuation and realization of **stock held for trading**.
* **Consistent Shareholder Returns:** Despite a net loss in FY23, the company has maintained a steady **final dividend of ₹1.25 per equity share** (Face Value **₹10**) for three consecutive years, demonstrating a commitment to payout consistency.
* **Exceptional Items:** In FY25, the company recognized an unfunded gratuity liability of **₹3,165.40 (in thousands)** as an exceptional item to align with actuarial valuations.
---
### Human Capital and Incentive Framework
To support its expansion, Elixir has overhauled its organizational structure and compensation strategy to attract top-tier talent.
* **Capital Base Expansion:** The **Authorized Share Capital** was recently increased from **₹6.00 Crore** to **₹8.00 Crore** (**80,00,000 shares**) to accommodate future growth and equity-based incentives.
* **ESOP Scheme 2024:** Administered by the **Nomination and Remuneration Committee (NRC)**, this scheme allows for the issuance of up to **20,00,000 Equity Shares**.
* **Recent Grants:** **62,854 options** were granted on **May 16, 2025**.
* **Vesting:** Minimum **1 year** and maximum **4 years** from the grant date.
* **Exercise Price:** Linked to **Market Price**, but not below the **Face Value of ₹10**.
* **Governance Enhancements:** The company adopted a **New Memorandum & Articles of Association** and appointed **Mrs. Manori Shah** as an **Independent Director** (term ending **March 2030**) to strengthen board oversight.
---
### Risk Management and Internal Controls
Elixir Capital employs a centralized risk framework focused on capital preservation and regulatory compliance.
| Risk Category | Exposure & Mitigation Strategy |
| :--- | :--- |
| **Market Risk** | High dependency on market cycles. Mitigated by diversifying into fee-based mutual fund distribution. |
| **Credit Risk** | Low. Cash is held only with **major banks with high-quality credit standing**. No material assets are past due. |
| **Liquidity Risk** | Managed through robust **Share Capital** and **Equity Reserves**. The company does not use **derivative instruments** for trading. |
| **Regulatory Risk** | Compliant with **Ind AS** and **SEBI (LODR)**. The company has **not** invested in **Cryptocurrencies** and has **no pending litigations**. |
The Board has concluded that there are no risks currently threatening the existence of the company. While a formal Risk Management Committee is not required under **Regulation 21 of SEBI**, the **Audit Committee** provides rigorous oversight of internal controls and transaction authorizations.